Leveraging our 85+ years of API development and manufacturing expertise to offer customized solutions.
With over 350 products in our portfolio, we’re the leading international supplier of APIs.
We’ll be showcasing our latest advancements in APIs and CDMO services, driven by our pillars of innovation and technology. Save the date and come visit us at our booth 3 A73 to discuss how we can support your next project!
Since our founding in 1935, TAPI has been at the forefront of advancing health through innovation and dedication. Today we continue to build on this strong legacy, driving progress in the pharmaceutical industry. Our commitment to health is unwavering, from developing high-quality generics to pioneering cutting edge solutions.
TAPI EHS&S Awards 2025: Celebrating the People Driving Safer, Smarter, More Sustainable Progress
Joint Interview: TAPI and Antheia on Partnership, Progress, and the Future of Pharma
Accelerating Peptide Innovation Through Science, Agility, and Collaboration
TAPI and Antheia Announce Strategic Partnership to Advance Commercialization of Biosynthetic Pharmaceutical Ingredients
Transforming GLP-1 Manufacturing with PAT-Generated Data: A Smarter, Greener Approach
Sustainable by Design: How TAPI is Building a Greener Future in API Manufacturing
Our CDMO team is heading to OPR&D Copenhagen. Join us to explore advances in process development, scale-up, and API manufacturing. Meet our team to discuss how TAPI’s scientific expertise and CDMO capabilities can support your next project.
Our CDMO team is heading to ADC San Diego! Join us to explore how TAPI’s expertise in complex chemistry, process development, scale-up, and manufacturing can support the evolving needs of ADC programs. Meet our team and discover how our CDMO capabilities can help advance your next project.
Our CDMO team is heading to TIDES Europe! Join us to explore how TAPI’s expertise in complex APIs, including peptides and oligonucleotides, can support your program from process development and scale-up through commercial manufacturing. Meet our team and discover how we can help advance your next project.
Our ESG commitment shapes how we develop, manufacture, and deliver active pharmaceutical ingredients (APIs) and CDMO services, with a long-term view toward shared value and global well-being.
We are committed to minimizing our environmental footprint by integrating eco-conscious practices into our production and supply chain. From investing in energy-efficient technologies to reducing water usage and chemical waste, we actively pursue greener processes without compromising quality or compliance.
We maintain rigorous compliance standards, transparent reporting, and ethical business practices across our global operations. From quality control to cybersecurity, our governance framework ensures accountability and risk management at every level.
People are at the heart of everything we do, and we collaborate with our partners and communities to promote health, education, and opportunity. Ethical labor practices, ongoing workforce development, and a commitment to health equity are key pillars of our social impact strategy.
